Study on migraine drugs and bladder symptoms
Treatments studied
Part of Brain & nervous system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how certain migraine treatments affect bladder symptoms like frequent or urgent urination. If you have hard-to-treat migraines and are starting a CGRP inhibitor or Botox injections, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman over 18 years old.
- You have migraines that don't respond well to other treatments.
- You are about to start a CGRP inhibitor (like Ubrogepant, Atogepant, or Erenumab) or get Botox injections for migraines.
- In the past month, you have had bladder symptoms: needing to urinate often, having a sudden strong urge to go, or leaking urine before reaching the toilet.
- You have not taken a CGRP drug in the last 12 months or had Botox in your head or bladder in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the migraine medication ubrogepant works when taken during the early signs of a migraine (prodrome). It may help people who already use ubrogepant for their migraines.
This trial tests whether using both a CGRP antibody and Botox together works better than the CGRP antibody alone for chronic migraine. It may help if you have not tried these treatments before.
This study tests how safe ubrogepant is and whether it helps treat an individual migraine attack in children and teens. It focuses on measuring side effects and whether headaches improve 2 hours after taking the study medicine.
This study tracks how well new migraine medications (like Aimovig, Emgality, Ajovy, Vyepti, Qulipta, and Nurtec) work in everyday use. It may help you and your doctor understand if these treatments are a good option for your migraines.
This early study tests a new medical system that measures pelvic and bladder pain patterns to help guide personalized botulinum toxin (BoNT) injections. It may help women with long-term bladder pain (interstitial cystitis/bladder pain syndrome) by improving how accurately treatment targets the pain source.
This study compares the usual amount of Botox injected into the bladder versus a smaller amount. It aims to see whether fewer injections can reduce overactive bladder symptoms with fewer side effects, like trouble emptying the bladder.
Hear when a new Overactive Bladder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.